TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Unknown
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

Scenic Biotech announced a license and research agreement with Ono Pharmaceutical to utilize its Cell-Seq platform for discovering novel therapeutic targets. This marks Scenic's fourth major pharmaceutical collaboration, joining existing partnerships with Genentech, Bristol Myers Squibb, and Alnylam.

Insights
BMY   neutral

Mentioned only as an existing partner with no new developments announced in this article.